Intracranial pressure (ICP) is monitored by placing a sensor inside the skull or, in some cases, using ultrasound-based techniques at the bedside. Normal ICP in adults ranges from about 7 to 15 mmHg when lying down. When pressure climbs above 20 to 25 mmHg, it can damage brain tissue and compromise blood flow, making accurate, continuous monitoring essential in intensive care.
When ICP Monitoring Is Needed
The Brain Trauma Foundation recommends ICP monitoring for all patients with severe traumatic brain injury (a Glasgow Coma Scale score of 3 to 8 after initial stabilization) who have an abnormal CT scan. Abnormal findings include blood clots, bruising of brain tissue, swelling, herniation, or compressed fluid spaces at the base of the brain.
Even with a normal CT scan, monitoring is indicated if two or more of the following are present at admission: age over 40, abnormal posturing movements on one or both sides of the body, or systolic blood pressure below 90 mmHg. Outside of trauma, ICP monitoring may also be used for conditions like hydrocephalus, brain tumors, or severe infections that raise pressure inside the skull.
External Ventricular Drains
An external ventricular drain (EVD) is considered the gold standard for ICP monitoring. A thin catheter is surgically inserted through a small hole in the skull and guided into one of the brain’s fluid-filled chambers (ventricles). This setup does two things at once: it measures pressure directly, and it allows cerebrospinal fluid (CSF) to be drained to lower that pressure when needed.
The trade-off is a higher complication rate compared to other devices. Infection is the primary concern. Published rates vary, but data from the CDC show infection rates ranging from roughly 0.7 to 6.5 per 1,000 catheter-days depending on the facility and time period. One large analysis found that EVDs carried about 2.5 times the overall complication risk of simpler monitors, driven mostly by infections such as meningitis. EVDs also tend to stay in place longer and are associated with longer ICU stays.
One important limitation: when an EVD is actively draining fluid, it may not capture sudden pressure spikes. The drain is typically clamped briefly to get an accurate reading, then reopened for drainage. Missing these pressure events can delay treatment if the team isn’t aware of the issue.
Intraparenchymal Monitors
An intraparenchymal monitor (IPM) is a small fiber-optic or strain-gauge sensor placed directly into the brain tissue through a bolt secured to the skull. It provides continuous, real-time pressure readings without the ability to drain fluid. Because it’s simpler to place and maintain, it carries a lower infection risk than an EVD.
The readings from intraparenchymal monitors correlate closely with EVD measurements, making them reliable for tracking pressure trends. Their main drawback is that they cannot treat elevated ICP the way an EVD can. In practice, about one in four patients who start with an intraparenchymal monitor eventually need an EVD placed later because their pressure rises and requires CSF drainage for control.
Reading the ICP Waveform
ICP isn’t just a single number. Each heartbeat produces a waveform with three distinct peaks, and the shape of that waveform reveals how well the brain is tolerating pressure changes.
- P1 (percussion wave): The first and normally tallest peak, caused by the arterial pulse pushing blood into the brain.
- P2 (tidal wave): The second peak, which reflects how compliant the brain and its surrounding structures are. In a healthy brain, P2 is shorter than P1.
- P3 (dicrotic wave): The third and smallest peak, corresponding to the closure of the aortic valve and venous outflow.
When P2 rises to equal or exceed P1, it signals that the brain’s ability to absorb pressure changes (its compliance) is deteriorating. If the waveform becomes so rounded that individual peaks can no longer be distinguished, the situation is considered clearly pathological. Clinicians watch for these shape changes as an early warning, sometimes before the raw pressure number itself crosses a dangerous threshold.
Slow Pressure Waves
Beyond the beat-to-beat waveform, ICP tracings can show slower oscillations known as B-waves. These occur at a frequency of roughly one cycle every 20 seconds to 3 minutes and reflect the brain’s blood vessel regulation cycling between dilation and constriction. A change in the pattern or intensity of B-waves suggests reduced intracranial compliance. Prolonged, high-amplitude plateau waves (historically called A-waves) are more ominous, representing sustained pressure elevations that can last 5 to 20 minutes and signal a dangerous loss of the brain’s ability to regulate its own blood flow.
Cerebral Perfusion Pressure
ICP monitoring becomes most useful when paired with blood pressure to calculate cerebral perfusion pressure (CPP), which estimates how much blood flow the brain is actually receiving. The formula is straightforward: CPP equals mean arterial pressure minus ICP. If a patient’s mean arterial pressure is 90 mmHg and their ICP is 20 mmHg, their CPP is 70 mmHg.
Maintaining adequate CPP is one of the central goals of neurocritical care. When ICP rises or blood pressure drops, CPP falls, and the brain receives less oxygen and nutrients. Treatment decisions in the ICU, from adjusting medications that support blood pressure to draining cerebrospinal fluid, often hinge on keeping CPP within a target range rather than focusing on ICP alone.
Non-Invasive Monitoring Methods
Because any device placed inside the skull carries infection and bleeding risks, there is strong interest in measuring ICP without surgery. Two ultrasound-based approaches have shown the most promise.
Optic nerve sheath diameter (ONSD) measurement uses a high-frequency ultrasound probe placed gently over the closed eyelid. The optic nerve is surrounded by a sheath that fills with cerebrospinal fluid, so when intracranial pressure rises, this sheath expands. By measuring its diameter about 3 mm behind the retina, clinicians get an indirect estimate of ICP. The technique is quick, portable, and repeatable.
Transcranial Doppler (TCD) ultrasound measures blood flow velocity in the brain’s major arteries through the thin bone of the temple. The pulsatility of that flow changes predictably as ICP rises: higher resistance inside the skull alters the pattern of blood moving through each heartbeat. A metric called the pulsatility index, derived from peak and trough flow speeds, correlates with ICP levels.
Neither technique alone matches the precision of an invasive monitor, but combining them improves accuracy significantly. A prospective study in PLOS Medicine found that pairing ONSD with venous transcranial Doppler measurements of a deep brain vein achieved an area under the curve of 0.93, a strong diagnostic performance for detecting elevated ICP. This combination approach is particularly valuable in settings where neurosurgical placement of an invasive monitor isn’t immediately available, or as a screening tool to decide whether invasive monitoring is warranted.
Choosing the Right Approach
The choice between monitoring methods depends on the clinical situation. EVDs are preferred when both monitoring and active pressure management through fluid drainage are needed, which is common in severe traumatic brain injury with rising ICP. Intraparenchymal monitors are a reasonable first step when the primary goal is trend monitoring without immediate need for drainage, keeping in mind that a quarter of patients may eventually require an upgrade to an EVD.
Non-invasive methods fill a different role entirely. They’re useful for initial assessment in emergency departments, for patients who aren’t candidates for surgery, or for serial checks in conditions like idiopathic intracranial hypertension where invasive monitoring would be disproportionate to the clinical need. They cannot replace continuous invasive monitoring in critically ill patients, but they add valuable data points and can guide early decision-making before a patient reaches the operating room.